TipRanks
Inmune Bio Inc (DE:0Y2)
BERLIN:0Y2
Germany Market
0Y2
Inmune Bio
RESEARCH TOOLSreports

Inmune Bio (0Y2) Stock News & Sentiment

0 Followers
INmune Bio Inc. and Quantum Computing Inc. Partner to Apply Quantum Optimization and AI to Advance Alzheimer’s Drug Research and Explore New Applications for XPro
Premium
TipRanks Newswire
INmune Bio Inc. and Quantum Computing Inc. Partner to Apply Quantum Optimization and AI to Advance Alzheimer’s Drug Research and Explore New Applications for XPro
7h ago
INMB
QUBT
Inmune Bio Adds Strategic Directors to Support Commercialization
Premium
Company Announcements
Inmune Bio Adds Strategic Directors to Support Commercialization
1M ago
8K
INMB
INmune Bio Earnings Call Highlights De-Risking, Cash Risks
Premium
Company Announcements
INmune Bio Earnings Call Highlights De-Risking, Cash Risks
2M ago
INMB
Jason McCarthy Reiterates Buy on INmune Bio, Keeps $8 Price Target Amid Advancing Clinical and Regulatory Milestones
Premium
Ratings
Jason McCarthy Reiterates Buy on INmune Bio, Keeps $8 Price Target Amid Advancing Clinical and Regulatory Milestones
2M ago
INMB
INmune Bio Strengthens Cash Runway With R&D Rebates
Premium
Company Announcements
INmune Bio Strengthens Cash Runway With R&D Rebates
3M ago
8K
INMB
Strengthening XPro1595 Data and De-Risked Registrational Path Support Buy Rating on INmune Bio with Unchanged $8 Price Target
Premium
Ratings
Strengthening XPro1595 Data and De-Risked Registrational Path Support Buy Rating on INmune Bio with Unchanged $8 Price Target
3M ago
INMB
INmune Bio Executes Warrant Inducement and Extension Agreement
Premium
Company Announcements
INmune Bio Executes Warrant Inducement and Extension Agreement
4M ago
8K
INMB
More DE:0Y2 News >

0Y2 News on the Web

Inmune Bio Adds Strategic Directors to Support Commercialization
TipRanks News
Neutral
INmune Bio Earnings Call Highlights De-Risking, Cash Risks
TipRanks News
Neutral
INmune Bio (INMB) Q2 2026 Earnings Call Transcript
The Motley Fool
Neutral
INmune Bio Executes Warrant Inducement and Extension Agreement
TipRanks News
Neutral
INmune Bio Secures Rapid UK Regulatory Progress for Ebstrocel, Paving Way for First Systemic RDEB Therapy
Market Chameleon
Neutral
INmune Bio Advances Ebstrocel Toward UK Conditional Approval
TipRanks News
Neutral
INmune Bio announces MHRA alignment in pre-MAA CORDStrom meeting
TipRanks News
Bullish
Inmune Bio Shareholders Reaffirm Board, Auditor and Incentive Plan
TipRanks News
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average1 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:0Y2’s Media Buzz Sentiment?
Currently, no data Available
What is DE:0Y2’s weekly average amount of articles?
In an average week, 1 articles about DE:0Y2 are published.
    What is DE:0Y2’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    GKOSGlaukos
    RYTMRhythm Pharmaceuticals
    DHRDanaher
    HALOHalozyme
    VRTXVertex Pharmaceuticals
    Showing the stocks with the most bullish news sentiment over the past week